Virax Biolabs Group Limited (VRAX)
NASDAQ: VRAX · Real-Time Price · USD
0.8500
-0.0099 (-1.15%)
Jul 3, 2025, 1:00 PM EDT - Market closed

Virax Biolabs Group Income Statement

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020
Period Ending
Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2020
0.010.160.01-0.12
Upgrade
Revenue Growth (YoY)
-95.95%1727.11%--23.97%
Upgrade
Cost of Revenue
0.060.110.01-0.13
Upgrade
Gross Profit
-0.050.05-0--0.01
Upgrade
Selling, General & Admin
4.334.593.551.30.51
Upgrade
Research & Development
1.781.562.180.430.12
Upgrade
Operating Expenses
6.116.165.731.730.64
Upgrade
Operating Income
-6.16-6.11-5.73-1.73-0.64
Upgrade
Interest Expense
-0.06-0.03-0.02-0.02-0.03
Upgrade
Other Non Operating Income (Expenses)
0.02-0.02-0-00
Upgrade
EBT Excluding Unusual Items
-6.2-6.15-5.75-1.75-0.67
Upgrade
Asset Writedown
--0.39---
Upgrade
Legal Settlements
--0.21---
Upgrade
Other Unusual Items
-0.010.29--
Upgrade
Pretax Income
-6.2-6.74-5.46-1.75-0.67
Upgrade
Income Tax Expense
-0.14----
Upgrade
Earnings From Continuing Operations
-6.07-6.74-5.46-1.75-0.67
Upgrade
Minority Interest in Earnings
0.010.0100.040.02
Upgrade
Net Income
-6.06-6.73-5.46-1.71-0.65
Upgrade
Net Income to Common
-6.06-6.73-5.46-1.71-0.65
Upgrade
Shares Outstanding (Basic)
42110
Upgrade
Shares Outstanding (Diluted)
42110
Upgrade
Shares Change (YoY)
85.92%88.75%11.15%297.67%130.43%
Upgrade
EPS (Basic)
-1.62-3.36-5.13-1.79-2.71
Upgrade
EPS (Diluted)
-1.62-3.36-5.13-1.79-2.71
Upgrade
Free Cash Flow
-5.17-7.2-4.18-0.81-0.59
Upgrade
Free Cash Flow Per Share
-1.39-3.59-3.93-0.85-2.45
Upgrade
Gross Margin
-32.34%-15.94%--7.62%
Upgrade
Operating Margin
-97344.76%-3903.69%-66963.68%--520.54%
Upgrade
Profit Margin
-95739.17%-4304.81%-63748.32%--525.75%
Upgrade
Free Cash Flow Margin
-81621.64%-4602.71%-48823.35%--476.65%
Upgrade
EBITDA
-5.9-6.05---
Upgrade
D&A For EBITDA
0.270.05---
Upgrade
EBIT
-6.16-6.11-5.73-1.73-0.64
Upgrade
Revenue as Reported
----0.12
Upgrade
Updated Nov 20, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q